My large LLY stake has my portfolio closing in on a new all-time high.
https://www.axios.com/2025/04/17/eli-lilly-glp-1-weight-loss
(( What we’re watching: Drug giants have been scrambling to boost production of GLP-1 medicines to meet demand after experiencing shortages in recent years due to soaring usage. }}
It’s a lot easier to stamp out a tablet than to manufacture an injectable drug in the antiseptic environment that rivals a semiconductor fab.
The manufacturing costs will be as cheap as aspirin.
intercst